Tanase Anna-Maria, Dumitrascu Traian, Dima Simona, Grigorie Razvan, Marchio Agnes, Pineau Pascal, Popescu Irinel
Center of General Surgery and Liver Transplant, Fundeni Clinical Institute, Fundeni Street No. 258, 022328, Bucharest, Romania.
Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):162-72. doi: 10.1016/s1499-3872(14)60026-6.
The global risk of hepatocellular carcinoma (HCC) is largely due to hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. In recent years, however, an increased prevalence of non-viral HCC has been noted. The clinical impact of the presence/absence of viral infections in HCC remains controversial. The present study aimed to assess the effect of hepatitis viruses on demographics, clinical and pathological features and long-term outcome in a large cohort of Romanian patients who underwent surgery for HCC.
The study included 404 patients with HCC who had undergone resection, transplantation or radiofrequency ablation at a single institution between 2001 and 2010. The patients were divided into four groups: 85 patients with hepatitis B virus infection (HBV group), 164 patients with hepatitis C virus infection (HCV group), 39 patients with hepatitis B and C virus co-infection (HBCV group), and 116 patients without viral infection (non-BC group).
The patients of both HBV (56.0+/-11.3 years) and HBCV groups (56.0+/-9.9 years) were significantly younger than those of the HCV (61.0+/-8.5 years, P=0.001) and non-BC groups (61.0+/-13.0 years, P=0.002). Interestingly, the prevalence of liver cirrhosis was significantly lower in the non-BC group (47%) than in any other subsets (72%-90%, P<0.002). Furthermore, the non-BC patients were more advanced according to the Barcelona Clinic Liver Cancer stages than the patients of the HCV or HBCV groups (P<0.020); accordingly, they were more frequently assessed beyond the Milan criteria than any other groups (P=0.001). No significant differences in the disease-free or overall survival rates were observed among these groups.
Patients with non-viral HCC are diagnosed at advanced ages and stages, a situation plausibly due to the poor effectiveness of cancer surveillance in community practice. The presence of viral infections does not appear to impair the long-term prognosis after surgical treatment in patients with HCC; however, there is a trend for worse disease-free survival rates in HBCV patients, though statistical significance was not reached.
肝细胞癌(HCC)的全球风险主要归因于乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染。然而,近年来,非病毒性HCC的患病率有所上升。HCC中病毒感染的存在与否对临床的影响仍存在争议。本研究旨在评估肝炎病毒对一大群接受HCC手术的罗马尼亚患者的人口统计学、临床和病理特征以及长期预后的影响。
该研究纳入了2001年至2010年间在单一机构接受切除、移植或射频消融的404例HCC患者。患者被分为四组:85例乙型肝炎病毒感染患者(HBV组),164例丙型肝炎病毒感染患者(HCV组),39例乙型和丙型肝炎病毒合并感染患者(HBCV组),以及116例无病毒感染患者(非BC组)。
HBV组(56.0±11.3岁)和HBCV组(56.0±9.9岁)的患者明显比HCV组(61.0±8.5岁,P = 0.001)和非BC组(61.0±13.0岁,P = 0.002)的患者年轻。有趣的是,非BC组肝硬化的患病率(47%)明显低于其他任何亚组(72% - 90%,P < 0.002)。此外,根据巴塞罗那临床肝癌分期,非BC组患者比HCV组或HBCV组患者病情更严重(P < 0.020);因此,他们超出米兰标准的评估频率比其他任何组都高(P = 0.001)。这些组之间在无病生存率或总生存率方面未观察到显著差异。
非病毒性HCC患者在高龄和晚期被诊断出来,这种情况可能是由于社区实践中癌症监测效果不佳所致。病毒感染的存在似乎并未损害HCC患者手术治疗后的长期预后;然而,HBCV患者的无病生存率有变差的趋势,尽管未达到统计学显著性。